Previously, factorial Mendelian Randomization analyses showed that genetically-influenced lower plasma TG levels via LPL have additional beneficial effects on reducing CAD risk on top of genetically-influenced lower LDL-C (21). The gene discussed is LPL; the disease is coronary artery disorder.